Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Nuclear Cardiology
Literature
1.
Loewe C, Stadler A. Computed tomography assessment of hemodynamic significance of coronary artery disease: CT perfusion, contrast gradients by coronary CTA, and fractional flow reserve review. J Thor Imag. 2014;20:163–72.CrossRef
2.
Le HQ, Ducote JL, Molloi S. Radiation dose reduction using a CdZnTe-based computed tomography system: comparison to flat-panel detectors. Med Phys. 2010;37:1225–36.CrossRefPubMedCentral
Metadata
Title
Perfusion debate
Author
H. William Strauss, MD
Publication date
01-12-2017
Publisher
Springer US
Published in
Journal of Nuclear Cardiology / Issue 6/2017
Print ISSN: 1071-3581
Electronic ISSN: 1532-6551
DOI
https://doi.org/10.1007/s12350-017-1026-5

Other articles of this Issue 6/2017

Journal of Nuclear Cardiology 6/2017 Go to the issue

Original Article

Current status of stress myocardial perfusion imaging pharmaceuticals and radiation exposure in Japan: Results from a nationwide survey

Original Article

Quantifying predictive accuracy in survival models

Editorial

Reducing radiation exposure from nuclear myocardial perfusion imaging: Time to act is now

Debate Article

PET should not replace routine SPECT MPS for the assessment of patients with known or suspected CAD

Editor's Page

Coronary vascular age comes of age

Images that Teach

Cardiac metastasis of clear cell thyroid cancer

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits